KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Invested Capital (2016 - 2025)

Evolent Health has reported Invested Capital over the past 12 years, most recently at $415.2 million for Q4 2025.

  • Quarterly results put Invested Capital at $415.2 million for Q4 2025, down 64.6% from a year ago — trailing twelve months through Dec 2025 was $415.2 million (down 64.6% YoY), and the annual figure for FY2025 was $415.2 million, down 64.6%.
  • Invested Capital for Q4 2025 was $415.2 million at Evolent Health, down from $847.4 million in the prior quarter.
  • Over the last five years, Invested Capital for EVH hit a ceiling of $1.2 billion in Q4 2024 and a floor of $415.2 million in Q4 2025.
  • Median Invested Capital over the past 5 years was $949.1 million (2022), compared with a mean of $884.2 million.
  • Biggest five-year swings in Invested Capital: soared 83.53% in 2023 and later crashed 64.6% in 2025.
  • Evolent Health's Invested Capital stood at $693.6 million in 2021, then rose by 23.9% to $859.4 million in 2022, then rose by 24.24% to $1.1 billion in 2023, then increased by 9.84% to $1.2 billion in 2024, then crashed by 64.6% to $415.2 million in 2025.
  • The last three reported values for Invested Capital were $415.2 million (Q4 2025), $847.4 million (Q3 2025), and $1.1 billion (Q2 2025) per Business Quant data.